Published online Jul 18, 2023. doi: 10.5312/wjo.v14.i7.572
Peer-review started: January 9, 2023
First decision: April 26, 2023
Revised: May 10, 2023
Accepted: May 31, 2023
Article in press: May 31, 2023
Published online: July 18, 2023
Processing time: 189 Days and 22.4 Hours
Active myofascial trigger points (MTrPs), commonly occurring in the upper region of the upper trapezius (UT), can be a significant source of neck, shoulder, upper back, and headache pain. This can negatively impact daily routine functioning, work-related productivity, and overall quality of life. With the rising prevalence of musculoskeletal pain and disability, it is critical to identify the most effective interventions to improve patient outcomes. This will reduce the societal burden.
Instrument assisted soft tissue mobilization (IASTM) and extracorporeal shock wave therapy (ESWT) are two treatment methods for MTrPs. Each method was tested independently and compared to another modality. To the author’s knowledge, this is the first study to compare IASTM vs ESWT on MTrPs of the UT.
This study compared the effects of IASTM vs ESWT in patients with UT MTrPs. These findings are critical in guiding the therapist in selecting treatment methods based on availability, cost, therapist experience, and patient preference.
Forty patients (28 females and 12 males) with active TrP in the UT muscle were randomly assigned to one of two equal groups (A and B). Group A received IASTM, while group B received ESWT. Each group received treatment twice a week for 2 weeks. Both groups received muscle energy technique for the UT muscle. Patients were assessed twice (pre-treatment and post-treatment) for pain intensity using the visual analog scale and pain pressure threshold (PPT) using a pressure algometer. A paired t-test was used to compare the pre-treatment and post-treatment mean values of all variables within both groups. For comparing all the dependent variables pre-treatment and post-treatment between both groups, we used an independent t-test. The significance level of a P value of ≤ 0.05 was considered statistically significant with a 95% confidence interval.
In group A (treated with IASTM) as well as in group B (treated with ESWT), there were significant differences between pre-treatment and post-treatment for pain intensity of TrP1 and TrP2 (P = 0.0001) and PPT for TrP1 and TrP2 (P = 0.0002 and P = 0.0001, respectively). There were no significant differences for pain intensity for TrP1 (P = 0.9), pain intensity for TrP2 (P = 0.76), PPT for TrP1 (P = 0.09), and PPT for TrP2 (P = 0.91) when comparing the post-treatment mean values between both groups.
IASTM and ESWT are effective methods for treating pain and PPT in patients with UT muscle TrPs. However, there is no statistically significant difference between the two methods.
Future research will be required to investigate the effect of only using IASTM and ESWT without other techniques that may influence the outcome.